pediatric oncology

Lantern Pharma Preps 2026 Trial for Rare Pediatric Brain Cancer After FDA Guidance

by | Oct 14, 2025
The North Texas biotech, which uses AI to accelerate cancer drug development, received FDA feedback to advance a new clinical study targeting a rare childhood brain tumor.
MORE